Corcept Therapeutics (HTD) Cash flow

3 Followers

Corcept Therapeutics Cash Flow

DE:HTD's free cash flow for Q2 2026 was $31.02M. For the 2026 fiscal year, DE:HTD's free cash flow was decreased by $-54.11M and operating cash flow was $33.54M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 142.00M	$ 198.07M	$ 127.04M	$ 120.32M	$ 167.89M
Investing Cash Flow	$ 69.76M	$ -177.60M	$ 90.91M	$ -114.33M	$ 136.13M
Financing Cash Flow	$ -220.37M	$ -28.35M	$ -148.72M	$ -17.28M	$ -302.59M
End Cash Position	$ 120.50M	$ 127.67M	$ 135.55M	$ 66.33M	$ 77.62M
Free Cash Flow	$ 141.78M	$ 195.90M	$ 126.90M	$ 119.91M	$ 167.42M

Currency in USD